Predict your next investment

HEALTHCARE | Medical Devices & Equipment / Therapeutic Devices

See what CB Insights has to offer


Unattributed | Alive

Total Raised


Last Raised

$80K | 11 yrs ago

About ThermalTherapeutic Systems

ThermalTherapeutic Systems is currently developing a portable next-generation perfusion device for international distribution.

ThermalTherapeutic Systems Headquarter Location

Pittsburgh, Pennsylvania, 15219,

United States

Latest ThermalTherapeutic Systems News

ThermalTherapeutic raising funds to commercialize perfusion device

Nov 15, 2011

Share / Nov 15, 2011 at 2:43 PM ThermalTherapeutic Systems has raised $800,000 toward a round of investment that will fund the commercial launch of its hyperthermic perfusion device. The portable device, called the VeraTherm , received U.S. Food and Drug Administration clearance in March 2010. The 26-pound device is used to pump heated or unheated fluid into patients’ abdomens or chest cavities. Hyperthermic perfusion is sometimes used in treating cancer. The procedure involves a warmed solution containing anticancer drugs that is used to bathe, or is passed through the blood vessels of, the tissue or organ containing a tumor. Newly hired CEO Gardiner Smith said the Pittsburgh-based company is in the midst of raising a series B round to fund commercialization of the device. A document filed with the U.S. Securities and Exchange Commission said the company was targeting $2 million for the round, but Smith said the amount of equity funding the company raises will likely depend on how well the device sells. Advertisement The latest funding comes from existing investors, including Bethlehem, Pennsylvania-based Originate Ventures , which led the company’s $2.75 million series A round in 2009, Smith said. ThermalTherapeutic is also looking to begin selling the device in international markets, according to Smith. “The hyperthermic perfusion market is one where the unmet medical need is high, and we believe it’s a largely untapped market,” Smith said.  

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.